DK149751C - Analogifremgangsmaade til fremstilling af et salt af et bistetrahydroisoquinolinium-derivat og mellemproduktforbindelsen til udaevelse af fremgangsmaaden - Google Patents

Analogifremgangsmaade til fremstilling af et salt af et bistetrahydroisoquinolinium-derivat og mellemproduktforbindelsen til udaevelse af fremgangsmaaden

Info

Publication number
DK149751C
DK149751C DK553676A DK553676A DK149751C DK 149751 C DK149751 C DK 149751C DK 553676 A DK553676 A DK 553676A DK 553676 A DK553676 A DK 553676A DK 149751 C DK149751 C DK 149751C
Authority
DK
Denmark
Prior art keywords
procedure
bistetrahydroisoquinolinium
presentation
derivative
salt
Prior art date
Application number
DK553676A
Other languages
Danish (da)
English (en)
Other versions
DK149751B (da
DK553676A (da
Inventor
John Bedford Stenlake
Roger David Waigh
George Henry Dewar
John Urwin
Nirmal Chandra Dhar
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26265501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK149751(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB4502876A external-priority patent/GB1579822A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK553676A publication Critical patent/DK553676A/da
Publication of DK149751B publication Critical patent/DK149751B/da
Application granted granted Critical
Publication of DK149751C publication Critical patent/DK149751C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK553676A 1975-12-10 1976-12-09 Analogifremgangsmaade til fremstilling af et salt af et bistetrahydroisoquinolinium-derivat og mellemproduktforbindelsen til udaevelse af fremgangsmaaden DK149751C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB5058975 1975-12-10
GB5058975 1975-12-10
GB4502876A GB1579822A (en) 1976-10-29 1976-10-29 Tetrahydroisoquinolinium muscle relaxants
GB4502876 1976-10-29

Publications (3)

Publication Number Publication Date
DK553676A DK553676A (da) 1977-06-11
DK149751B DK149751B (da) 1986-09-22
DK149751C true DK149751C (da) 1987-03-23

Family

ID=26265501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK553676A DK149751C (da) 1975-12-10 1976-12-09 Analogifremgangsmaade til fremstilling af et salt af et bistetrahydroisoquinolinium-derivat og mellemproduktforbindelsen til udaevelse af fremgangsmaaden

Country Status (24)

Country Link
US (1) US4179507A (xx)
JP (1) JPS6043342B2 (xx)
AT (1) AT365579B (xx)
AU (1) AU506657B2 (xx)
CA (1) CA1075241A (xx)
CH (1) CH625223A5 (xx)
CY (1) CY1217A (xx)
DD (1) DD128320A5 (xx)
DE (1) DE2655883A1 (xx)
DK (1) DK149751C (xx)
FI (1) FI61485C (xx)
FR (1) FR2334359A1 (xx)
HK (1) HK35084A (xx)
IE (1) IE44569B1 (xx)
IL (1) IL51074A (xx)
IT (1) IT1188908B (xx)
KE (1) KE3361A (xx)
LU (1) LU76355A1 (xx)
MC (1) MC1119A1 (xx)
MY (1) MY8500287A (xx)
NL (1) NL178688C (xx)
NZ (1) NZ182847A (xx)
SE (1) SE434154B (xx)
SU (1) SU718008A3 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
US4315935A (en) * 1980-04-14 1982-02-16 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use
US4317826A (en) * 1980-05-27 1982-03-02 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4 tetrahydroisoquinolyl]disulfonylimides and antiallergic compositions and method of use
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
GB9015473D0 (en) 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
US5684154A (en) * 1996-02-16 1997-11-04 Abbott Laboratories Process for the preparation and isolation of atracurium besylate
ES2210757T3 (es) 1997-03-25 2004-07-01 Avera Pharmaceuticals, Inc. Isoquinolinas sustituidas como bloqueadores neuromusculares de accion ultracorta.
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
BRPI0808272A2 (pt) * 2007-03-08 2014-07-08 Chemagis Ltd "método para cromatograficamente separar o isômero 1r-cis, 1´r-cis de uma mistura de isômeros de (1r-1'r) - atracúrio, besilato de cisatracúrio e isômero 1r-cis, 1'r-cis do besilato de cisatracúrio"
BRPI0808581A2 (pt) * 2007-03-26 2014-09-16 Chemagis Ltd "método para separar cisatracúrio com alta pureza de uma mistura de isômeros de (1r, 1'r) - atracúrio"
CA2685491A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
CA2685488A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
BRPI0811687A2 (pt) * 2007-06-18 2015-02-18 Chemagis Ltd MÉTODO PARA SEPARAR O ISÔMETRO 1R-CIS, 1'R-CIS (cisatracúrio) DE UMA MISTURA DE ISÔMEROS DE SAIS DE (1R, 1'R) - ATRACÚRIO
CN101337935B (zh) * 2007-07-06 2011-01-12 江苏恒瑞医药股份有限公司 一种用两相萃取法纯化苯磺酸阿曲库铵的方法
CN101337936B (zh) * 2007-07-06 2011-03-23 江苏恒瑞医药股份有限公司 一种用柱色谱法纯化苯磺酸阿曲库铵的方法
EP2176227A1 (en) * 2007-07-09 2010-04-21 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
BRPI0816519A2 (pt) * 2007-10-29 2015-03-24 Chemagis Ltd Processo para preparar um sal de r, r'-atracúrio isomericamente enriquecido e sal de r, r'-atracúrio
WO2009133556A2 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
KR101720154B1 (ko) * 2009-04-14 2017-03-27 글락소 그룹 리미티드 바이페닐­2­일카르밤산 에스테르의 제조 방법
WO2011022491A1 (en) 2009-08-19 2011-02-24 Cornell University Cysteine for physiological injection
EP2514754B1 (en) 2011-04-08 2013-08-21 King Saud University 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
CN102249998B (zh) * 2011-06-20 2013-09-25 浙江仙琚制药股份有限公司 一种制备顺苯磺酸阿曲库铵的方法
CN102898370A (zh) * 2012-11-11 2013-01-30 苏州二叶制药有限公司 注射用顺苯磺阿曲库铵
WO2018193463A1 (en) * 2017-04-21 2018-10-25 Neon Laboratories Limited An improved process for the preparation of tetrahydroisoquinoline compounds
CN114181147A (zh) * 2021-12-27 2022-03-15 上海药坦药物研究开发有限公司 一种苯磺阿曲库铵的处理方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB1125619A (en) * 1965-11-15 1968-08-28 Wellcome Found Derivatives of bis-isoquinolines

Also Published As

Publication number Publication date
DD128320A5 (de) 1977-11-09
KE3361A (en) 1984-02-17
IT8048000A0 (it) 1980-02-25
SU718008A3 (ru) 1980-02-25
US4179507A (en) 1979-12-18
JPS5277069A (en) 1977-06-29
DK149751B (da) 1986-09-22
ATA908476A (de) 1981-06-15
NL7613695A (nl) 1977-06-14
CH625223A5 (xx) 1981-09-15
LU76355A1 (xx) 1977-06-24
AU506657B2 (en) 1980-01-17
CA1075241A (en) 1980-04-08
FI61485B (fi) 1982-04-30
DE2655883A1 (de) 1977-06-23
IT8048000A1 (it) 1981-08-25
AU2037576A (en) 1978-06-15
IL51074A (en) 1980-05-30
MC1119A1 (fr) 1977-08-12
IE44569B1 (en) 1982-01-13
NL178688C (nl) 1986-05-01
NL178688B (nl) 1985-12-02
SE434154B (sv) 1984-07-09
FI61485C (fi) 1982-08-10
DE2655883C2 (xx) 1990-02-01
NZ182847A (en) 1979-06-08
DK553676A (da) 1977-06-11
AT365579B (de) 1982-01-25
FR2334359B1 (xx) 1981-10-16
MY8500287A (en) 1985-12-31
HK35084A (en) 1984-04-27
CY1217A (en) 1984-04-06
IL51074A0 (en) 1977-02-28
FR2334359A1 (fr) 1977-07-08
FI763543A (xx) 1977-06-11
JPS6043342B2 (ja) 1985-09-27
IT1188908B (it) 1988-01-28
SE7613824L (sv) 1977-06-11
IE44569L (en) 1977-06-10

Similar Documents

Publication Publication Date Title
DK149751C (da) Analogifremgangsmaade til fremstilling af et salt af et bistetrahydroisoquinolinium-derivat og mellemproduktforbindelsen til udaevelse af fremgangsmaaden
DK483176A (da) Fremgangsmade til fremstilling af et kemoterapeutikum
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK113676A (da) Fremgangsmade til fremstilling af et retardpreparat
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK518176A (da) Fremgangsmade til fremstilling af polyprenylderivater
DK145228C (da) Analogifremgangsmaade til fremstilling af 3-amino-4-deoxo-4-iminorifamycinderivater
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK155002C (da) Analogifremgangsmaade til fremstilling af salicylanilidderivater
DK360576A (da) Fremgangsmade til fremstilling af pyridinderivater
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK397076A (da) Fremgangsmade til fremstilling af nikotinamid
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK140172C (da) Fremgangsmaade til fremstilling af 5-androsten-17-on-derivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK442975A (da) Fremgangsmade til fremstilling af et svovlholdigt pyridinderivat
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK319276A (da) Fremgangsmade til femstilling af nitroquinolinderivater
DK140576A (da) Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater

Legal Events

Date Code Title Description
PUP Patent expired